Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wuxi AppTec CoWUXIF 75 Net-Net Working Capital is $1.51 as of Mar. 2026. GuruFocus rates WUXIF with a GF Score™ of 75/100 and a GF Value™ of $12.42 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 79 Medical Diagnostics & Research companies, Wuxi AppTec Co ranks worse than 67.09% on this metric.
In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.
Wuxi AppTec Co's Net-Net Working Capital for the quarter that ended in Mar. 2026 was $1.51.
The industry rank for Wuxi AppTec Co's Net-Net Working Capital or its related term are showing as below:
WUXIF's Price-to-Net-Net-Working-Capital is ranked worse than 67.09% of 79
companies
in the Medical Diagnostics & Research industry
Industry Median: 5.65
vs WUXIF: 12.07
Wuxi AppTec Co (OTCPK:WUXIF) Net-Net Working Capital Explanation
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.
Wuxi AppTec Co Net-Net Working Capital Related Terms
Wuxi AppTec Co Net-Net Working Capital Historical Data
* Premium members only.
The historical data trend for Wuxi AppTec Co's Net-Net Working Capital can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WUXIF vs TMO, DHR, IDXX: Net-Net Working Capital Comparison
For the Diagnostics & Research subindustry, Wuxi AppTec Co's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wuxi AppTec Co Price-to-Net-Net-Working-Capital vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's Price-to-Net-Net-Working-Capital distribution charts can be found below:
* The bar in red indicates where Wuxi AppTec Co's Price-to-Net-Net-Working-Capital falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.
In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
This is a conservative way of estimating the company's value.
What does a Net-Net Working Capital of $1.51 mean?
Wuxi AppTec Co (WUXIF) has a Net-Net Working Capital of $1.51 as of Mar. 2026. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Wuxi AppTec Co According to the industry distribution chart, Wuxi AppTec Co ranks #53 out of 79 companies in the Medical Diagnostics & Research industry, placing it in the top 67.1%.
Is Wuxi AppTec Co's Net-Net Working Capital too high?
Wuxi AppTec Co's current Net-Net Working Capital is $1.51. The Medical Diagnostics & Research industry median Net-Net Working Capital is 5.65. Wuxi AppTec Co's value of $1.51 is 73.3% below this industry median. Based on the distribution chart, Wuxi AppTec Co ranks #53 out of 79 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Wuxi AppTec Co has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wuxi AppTec Co's Net-Net Working Capital compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Wuxi AppTec Co ranks #53 out of 79 companies for Net-Net Working Capital. This places Wuxi AppTec Co in the lower half of its industry. The industry median Net-Net Working Capital is 5.65. Wuxi AppTec Co's value of $1.51 is 73.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net-Net Working Capital for a Medical Diagnostics & Research company?
The median Net-Net Working Capital among Medical Diagnostics & Research companies is 5.65, based on 79 companies in the industry. Companies in the top quartile (top 25%) have a Net-Net Working Capital significantly above this median, while those in the bottom quartile fall well below. However, Net-Net Working Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wuxi AppTec Co's current Net-Net Working Capital of $1.51 is 73.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net-Net Working Capital mean?
A high Net-Net Working Capital can signal that a stock is expensive relative to its fundamentals. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Wuxi AppTec Co For the Medical Diagnostics & Research industry, the median Net-Net Working Capital is 5.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wuxi AppTec Co's current Net-Net Working Capital is $1.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wuxi AppTec Co stock overvalued right now?
Based on GuruFocus' analysis, Wuxi AppTec Co (WUXIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $12.42, compared to a current price of $22.70 — trading 82.8% above its estimated fair value. The current Net-Net Working Capital is $1.51 and 73.3% below the Medical Diagnostics & Research industry median of 5.65. Wuxi AppTec Co's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net-Net Working Capital calculated?
Net-Net Working Capital is calculated from a company's financial statements. For Wuxi AppTec Co (WUXIF), the current Net-Net Working Capital is $1.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wuxi AppTec Co (WUXIF) Overvalued in 2026?
Based on GuruFocus' analysis, Wuxi AppTec Co stock appears to be overvalued.
The current stock price of $22.70 is trading 82.8% above its estimated GF Value™ of $12.42.
GuruFocus considers Wuxi AppTec Co to be Significantly Overvalued.
Key valuation signals for WUXIF:
Net-Net Working Capital: $1.51
GF Value™: $12.42 vs. price of $22.70 (82.8% above fair value)
Industry Position: 73.3% below the Medical Diagnostics & Research median (#53 of 79)
No single metric tells the full story. See the WUXIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.
75GF Score
Get the complete analysis for WUXIF
Net-Net Working Capital is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WUXIF has been successfully added to your 
